L2 capsid protein-targeting monovalent vaccine (Advanced Cancer Therapeutics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameL2 capsid protein-targeting monovalent vaccine (Advanced Cancer Therapeutics)
Drug Alias NameL2 capsid protein-targeting monovalent vaccine (University of Louisville)L2 capsid protein-targeting vaccine (University of Louisville)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Louisville
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of LouisvilleAdvanced Cancer Therapeutics Llc
Active IndicationsN/A
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A